nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—NR3C1—obesity	0.458	1	CbGaD
Budesonide—CYP3A4—Sibutramine—obesity	0.0691	0.27	CbGbCtD
Budesonide—CYP3A4—Benzphetamine—obesity	0.0524	0.204	CbGbCtD
Budesonide—CYP3A4—Bupropion—obesity	0.0446	0.174	CbGbCtD
Budesonide—CYP3A4—Orlistat—obesity	0.0363	0.142	CbGbCtD
Budesonide—CYP3A4—Cimetidine—obesity	0.0327	0.127	CbGbCtD
Budesonide—CYP3A4—Topiramate—obesity	0.0214	0.0834	CbGbCtD
Budesonide—Prednisone—HSD11B1—obesity	0.000769	0.12	CrCbGaD
Budesonide—Ciclesonide—CES1—obesity	0.000618	0.0962	CrCbGaD
Budesonide—Testolactone—CYP19A1—obesity	0.000283	0.0441	CrCbGaD
Budesonide—Clocortolone—NR3C1—obesity	0.00023	0.0358	CrCbGaD
Budesonide—Prednicarbate—NR3C1—obesity	0.00023	0.0358	CrCbGaD
Budesonide—Desonide—NR3C1—obesity	0.000217	0.0338	CrCbGaD
Budesonide—Diflorasone—NR3C1—obesity	0.000217	0.0338	CrCbGaD
Budesonide—Desoximetasone—NR3C1—obesity	0.000212	0.033	CrCbGaD
Budesonide—Loteprednol—NR3C1—obesity	0.000209	0.0326	CrCbGaD
Budesonide—Palpitations—Orlistat—obesity	0.0002	0.000927	CcSEcCtD
Budesonide—Angiopathy—Bupropion—obesity	0.000199	0.000922	CcSEcCtD
Budesonide—Migraine—Topiramate—obesity	0.000199	0.000922	CcSEcCtD
Budesonide—Affect lability—Topiramate—obesity	0.000199	0.000922	CcSEcCtD
Budesonide—Nausea—Cimetidine—obesity	0.000199	0.000921	CcSEcCtD
Budesonide—Immune system disorder—Bupropion—obesity	0.000199	0.000918	CcSEcCtD
Budesonide—Mediastinal disorder—Bupropion—obesity	0.000198	0.000916	CcSEcCtD
Budesonide—Malaise—Sibutramine—obesity	0.000198	0.000916	CcSEcCtD
Budesonide—Cough—Orlistat—obesity	0.000198	0.000915	CcSEcCtD
Budesonide—Psychotic disorder—Topiramate—obesity	0.000198	0.000914	CcSEcCtD
Budesonide—Vertigo—Sibutramine—obesity	0.000197	0.000912	CcSEcCtD
Budesonide—Syncope—Sibutramine—obesity	0.000197	0.00091	CcSEcCtD
Budesonide—Face oedema—Topiramate—obesity	0.000195	0.000904	CcSEcCtD
Budesonide—Alopecia—Bupropion—obesity	0.000194	0.000898	CcSEcCtD
Budesonide—Palpitations—Sibutramine—obesity	0.000194	0.000897	CcSEcCtD
Budesonide—Irritability—Topiramate—obesity	0.000193	0.000894	CcSEcCtD
Budesonide—Chest pain—Orlistat—obesity	0.000193	0.000893	CcSEcCtD
Budesonide—Myalgia—Orlistat—obesity	0.000193	0.000893	CcSEcCtD
Budesonide—Loss of consciousness—Sibutramine—obesity	0.000193	0.000892	CcSEcCtD
Budesonide—Mental disorder—Bupropion—obesity	0.000193	0.000891	CcSEcCtD
Budesonide—Anxiety—Orlistat—obesity	0.000192	0.00089	CcSEcCtD
Budesonide—Mood swings—Topiramate—obesity	0.000192	0.000887	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000192	0.000887	CcSEcCtD
Budesonide—Cough—Sibutramine—obesity	0.000192	0.000886	CcSEcCtD
Budesonide—Malnutrition—Bupropion—obesity	0.000191	0.000885	CcSEcCtD
Budesonide—Discomfort—Orlistat—obesity	0.000191	0.000882	CcSEcCtD
Budesonide—Hypertension—Sibutramine—obesity	0.00019	0.000876	CcSEcCtD
Budesonide—Dry mouth—Orlistat—obesity	0.000189	0.000873	CcSEcCtD
Budesonide—Flatulence—Bupropion—obesity	0.000189	0.000872	CcSEcCtD
Budesonide—Tension—Bupropion—obesity	0.000188	0.000868	CcSEcCtD
Budesonide—Dysgeusia—Bupropion—obesity	0.000187	0.000867	CcSEcCtD
Budesonide—Myalgia—Sibutramine—obesity	0.000187	0.000864	CcSEcCtD
Budesonide—Chest pain—Sibutramine—obesity	0.000187	0.000864	CcSEcCtD
Budesonide—Arthralgia—Sibutramine—obesity	0.000187	0.000864	CcSEcCtD
Budesonide—Anxiety—Sibutramine—obesity	0.000186	0.000861	CcSEcCtD
Budesonide—Nervousness—Bupropion—obesity	0.000186	0.00086	CcSEcCtD
Budesonide—Flurandrenolide—NR3C1—obesity	0.000186	0.0289	CrCbGaD
Budesonide—Anaphylactic shock—Orlistat—obesity	0.000185	0.000856	CcSEcCtD
Budesonide—Back pain—Bupropion—obesity	0.000185	0.000856	CcSEcCtD
Budesonide—Abdominal pain upper—Topiramate—obesity	0.000185	0.000855	CcSEcCtD
Budesonide—Discomfort—Sibutramine—obesity	0.000185	0.000854	CcSEcCtD
Budesonide—Hypokalaemia—Topiramate—obesity	0.000184	0.000852	CcSEcCtD
Budesonide—Muscle spasms—Bupropion—obesity	0.000184	0.000851	CcSEcCtD
Budesonide—Infection—Orlistat—obesity	0.000184	0.000851	CcSEcCtD
Budesonide—Breast disorder—Topiramate—obesity	0.000183	0.000846	CcSEcCtD
Budesonide—Dry mouth—Sibutramine—obesity	0.000183	0.000845	CcSEcCtD
Budesonide—Nervous system disorder—Orlistat—obesity	0.000182	0.00084	CcSEcCtD
Budesonide—Nasopharyngitis—Topiramate—obesity	0.000181	0.000837	CcSEcCtD
Budesonide—Confusional state—Sibutramine—obesity	0.000181	0.000835	CcSEcCtD
Budesonide—Vision blurred—Bupropion—obesity	0.00018	0.000834	CcSEcCtD
Budesonide—Skin disorder—Orlistat—obesity	0.00018	0.000832	CcSEcCtD
Budesonide—Hydrocortamate—NR3C1—obesity	0.00018	0.0279	CrCbGaD
Budesonide—Tremor—Bupropion—obesity	0.000179	0.000829	CcSEcCtD
Budesonide—Anaphylactic shock—Sibutramine—obesity	0.000179	0.000829	CcSEcCtD
Budesonide—Hyperhidrosis—Orlistat—obesity	0.000179	0.000828	CcSEcCtD
Budesonide—Infection—Sibutramine—obesity	0.000178	0.000823	CcSEcCtD
Budesonide—Ill-defined disorder—Bupropion—obesity	0.000178	0.000821	CcSEcCtD
Budesonide—Anaemia—Bupropion—obesity	0.000177	0.000818	CcSEcCtD
Budesonide—Shock—Sibutramine—obesity	0.000176	0.000815	CcSEcCtD
Budesonide—Abdominal distension—Topiramate—obesity	0.000176	0.000815	CcSEcCtD
Budesonide—Agitation—Bupropion—obesity	0.000176	0.000813	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CPT1A—obesity	0.000175	0.00278	CbGpPWpGaD
Budesonide—Angioedema—Bupropion—obesity	0.000175	0.000809	CcSEcCtD
Budesonide—Tachycardia—Sibutramine—obesity	0.000175	0.000809	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—obesity	0.000175	0.00278	CbGpPWpGaD
Budesonide—Skin disorder—Sibutramine—obesity	0.000174	0.000805	CcSEcCtD
Budesonide—Hyperhidrosis—Sibutramine—obesity	0.000173	0.000801	CcSEcCtD
Budesonide—Malaise—Bupropion—obesity	0.000173	0.000798	CcSEcCtD
Budesonide—Vertigo—Bupropion—obesity	0.000172	0.000795	CcSEcCtD
Budesonide—Syncope—Bupropion—obesity	0.000172	0.000794	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—GCK—obesity	0.000171	0.00271	CbGpPWpGaD
Budesonide—Anorexia—Sibutramine—obesity	0.000171	0.00079	CcSEcCtD
Budesonide—Sweating increased—Topiramate—obesity	0.00017	0.000788	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—AGT—obesity	0.000169	0.00269	CbGpPWpGaD
Budesonide—Palpitations—Bupropion—obesity	0.000169	0.000782	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Orlistat—obesity	0.000169	0.00078	CcSEcCtD
Budesonide—Bronchitis—Topiramate—obesity	0.000168	0.000778	CcSEcCtD
Budesonide—Loss of consciousness—Bupropion—obesity	0.000168	0.000778	CcSEcCtD
Budesonide—Insomnia—Orlistat—obesity	0.000167	0.000774	CcSEcCtD
Budesonide—Cough—Bupropion—obesity	0.000167	0.000772	CcSEcCtD
Budesonide—Amcinonide—NR3C1—obesity	0.000167	0.026	CrCbGaD
Budesonide—Paraesthesia—Orlistat—obesity	0.000166	0.000769	CcSEcCtD
Budesonide—Hypertension—Bupropion—obesity	0.000165	0.000764	CcSEcCtD
Budesonide—Dysuria—Topiramate—obesity	0.000164	0.000757	CcSEcCtD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP26B1—obesity	0.000164	0.0026	CbGpPWpGaD
Budesonide—Musculoskeletal discomfort—Sibutramine—obesity	0.000163	0.000755	CcSEcCtD
Budesonide—Dyspepsia—Orlistat—obesity	0.000163	0.000754	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TF—obesity	0.000163	0.00259	CbGpPWpGaD
Budesonide—Myalgia—Bupropion—obesity	0.000163	0.000753	CcSEcCtD
Budesonide—Arthralgia—Bupropion—obesity	0.000163	0.000753	CcSEcCtD
Budesonide—Chest pain—Bupropion—obesity	0.000163	0.000753	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—ADIPOQ—obesity	0.000163	0.00259	CbGpPWpGaD
Budesonide—Anxiety—Bupropion—obesity	0.000162	0.000751	CcSEcCtD
Budesonide—Insomnia—Sibutramine—obesity	0.000162	0.000749	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000162	0.000748	CcSEcCtD
Budesonide—Pollakiuria—Topiramate—obesity	0.000162	0.000748	CcSEcCtD
Budesonide—Discomfort—Bupropion—obesity	0.000161	0.000744	CcSEcCtD
Budesonide—Decreased appetite—Orlistat—obesity	0.000161	0.000744	CcSEcCtD
Budesonide—Paraesthesia—Sibutramine—obesity	0.000161	0.000744	CcSEcCtD
Budesonide—Gastrointestinal disorder—Orlistat—obesity	0.00016	0.000739	CcSEcCtD
Budesonide—Dyspnoea—Sibutramine—obesity	0.00016	0.000739	CcSEcCtD
Budesonide—Fatigue—Orlistat—obesity	0.00016	0.000738	CcSEcCtD
Budesonide—Dry mouth—Bupropion—obesity	0.000159	0.000737	CcSEcCtD
Budesonide—Somnolence—Sibutramine—obesity	0.000159	0.000737	CcSEcCtD
Budesonide—Weight increased—Topiramate—obesity	0.000159	0.000736	CcSEcCtD
Budesonide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—obesity	0.000159	0.00253	CbGpPWpGaD
Budesonide—Mometasone—NR3C1—obesity	0.000159	0.0247	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—ESR1—obesity	0.000158	0.00252	CbGpPWpGaD
Budesonide—Pain—Orlistat—obesity	0.000158	0.000732	CcSEcCtD
Budesonide—NR3C1—Circadian Clock—SERPINE1—obesity	0.000158	0.00251	CbGpPWpGaD
Budesonide—Dyspepsia—Sibutramine—obesity	0.000158	0.000729	CcSEcCtD
Budesonide—Confusional state—Bupropion—obesity	0.000158	0.000728	CcSEcCtD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—obesity	0.000157	0.00249	CbGpPWpGaD
Budesonide—Rimexolone—NR3C1—obesity	0.000157	0.0244	CrCbGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—obesity	0.000156	0.00248	CbGpPWpGaD
Budesonide—Anaphylactic shock—Bupropion—obesity	0.000156	0.000722	CcSEcCtD
Budesonide—Infestation NOS—Topiramate—obesity	0.000156	0.000722	CcSEcCtD
Budesonide—Infestation—Topiramate—obesity	0.000156	0.000722	CcSEcCtD
Budesonide—Decreased appetite—Sibutramine—obesity	0.000156	0.00072	CcSEcCtD
Budesonide—Infection—Bupropion—obesity	0.000155	0.000718	CcSEcCtD
Budesonide—Gastrointestinal disorder—Sibutramine—obesity	0.000155	0.000715	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—SLC2A4—obesity	0.000154	0.00244	CbGpPWpGaD
Budesonide—Shock—Bupropion—obesity	0.000154	0.000711	CcSEcCtD
Budesonide—Pain—Sibutramine—obesity	0.000153	0.000709	CcSEcCtD
Budesonide—Constipation—Sibutramine—obesity	0.000153	0.000709	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—obesity	0.000153	0.00243	CbGpPWpGaD
Budesonide—Nervous system disorder—Bupropion—obesity	0.000153	0.000708	CcSEcCtD
Budesonide—Feeling abnormal—Orlistat—obesity	0.000153	0.000705	CcSEcCtD
Budesonide—Tachycardia—Bupropion—obesity	0.000152	0.000705	CcSEcCtD
Budesonide—Skin disorder—Bupropion—obesity	0.000152	0.000702	CcSEcCtD
Budesonide—Conjunctivitis—Topiramate—obesity	0.000152	0.000701	CcSEcCtD
Budesonide—Urinary tract infection—Topiramate—obesity	0.000152	0.000701	CcSEcCtD
Budesonide—Gastrointestinal pain—Orlistat—obesity	0.000151	0.0007	CcSEcCtD
Budesonide—Hyperhidrosis—Bupropion—obesity	0.000151	0.000698	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—obesity	0.000149	0.00237	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—obesity	0.000149	0.00237	CbGpPWpGaD
Budesonide—Anorexia—Bupropion—obesity	0.000149	0.000689	CcSEcCtD
Budesonide—Haematuria—Topiramate—obesity	0.000149	0.000688	CcSEcCtD
Budesonide—Beclomethasone—NR3C1—obesity	0.000148	0.023	CrCbGaD
Budesonide—Fluocinonide—NR3C1—obesity	0.000148	0.023	CrCbGaD
Budesonide—Feeling abnormal—Sibutramine—obesity	0.000148	0.000683	CcSEcCtD
Budesonide—Epistaxis—Topiramate—obesity	0.000147	0.000681	CcSEcCtD
Budesonide—Urticaria—Orlistat—obesity	0.000147	0.00068	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—NCOA1—obesity	0.000147	0.00233	CbGpPWpGaD
Budesonide—Gastrointestinal pain—Sibutramine—obesity	0.000147	0.000678	CcSEcCtD
Budesonide—Sinusitis—Topiramate—obesity	0.000146	0.000677	CcSEcCtD
Budesonide—Abdominal pain—Orlistat—obesity	0.000146	0.000677	CcSEcCtD
Budesonide—Body temperature increased—Orlistat—obesity	0.000146	0.000677	CcSEcCtD
Budesonide—Fluocinolone Acetonide—NR3C1—obesity	0.000144	0.0224	CrCbGaD
Budesonide—Alclometasone—NR3C1—obesity	0.000144	0.0224	CrCbGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—obesity	0.000143	0.00228	CbGpPWpGaD
Budesonide—Urticaria—Sibutramine—obesity	0.000142	0.000658	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Bupropion—obesity	0.000142	0.000658	CcSEcCtD
Budesonide—Body temperature increased—Sibutramine—obesity	0.000142	0.000655	CcSEcCtD
Budesonide—Abdominal pain—Sibutramine—obesity	0.000142	0.000655	CcSEcCtD
Budesonide—Insomnia—Bupropion—obesity	0.000141	0.000653	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—obesity	0.000141	0.00224	CbGpPWpGaD
Budesonide—Haemoglobin—Topiramate—obesity	0.000141	0.000651	CcSEcCtD
Budesonide—Rhinitis—Topiramate—obesity	0.00014	0.000649	CcSEcCtD
Budesonide—Paraesthesia—Bupropion—obesity	0.00014	0.000649	CcSEcCtD
Budesonide—Haemorrhage—Topiramate—obesity	0.00014	0.000648	CcSEcCtD
Budesonide—Clobetasol propionate—NR3C1—obesity	0.00014	0.0218	CrCbGaD
Budesonide—Flunisolide—NR3C1—obesity	0.00014	0.0218	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—CCL2—obesity	0.000139	0.00222	CbGpPWpGaD
Budesonide—Dyspnoea—Bupropion—obesity	0.000139	0.000644	CcSEcCtD
Budesonide—Pharyngitis—Topiramate—obesity	0.000139	0.000643	CcSEcCtD
Budesonide—Somnolence—Bupropion—obesity	0.000139	0.000642	CcSEcCtD
Budesonide—Urinary tract disorder—Topiramate—obesity	0.000138	0.00064	CcSEcCtD
Budesonide—Paramethasone—NR3C1—obesity	0.000138	0.0215	CrCbGaD
Budesonide—Oedema peripheral—Topiramate—obesity	0.000138	0.000638	CcSEcCtD
Budesonide—Connective tissue disorder—Topiramate—obesity	0.000138	0.000637	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—ESR2—obesity	0.000138	0.00219	CbGpPWpGaD
Budesonide—Dyspepsia—Bupropion—obesity	0.000138	0.000636	CcSEcCtD
Budesonide—Urethral disorder—Topiramate—obesity	0.000137	0.000635	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—obesity	0.000137	0.00218	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—SOCS1—obesity	0.000137	0.00218	CbGpPWpGaD
Budesonide—Hypersensitivity—Orlistat—obesity	0.000136	0.000631	CcSEcCtD
Budesonide—Ciclesonide—NR3C1—obesity	0.000136	0.0212	CrCbGaD
Budesonide—Decreased appetite—Bupropion—obesity	0.000136	0.000628	CcSEcCtD
Budesonide—Triamcinolone—BCHE—obesity	0.000136	0.0211	CrCbGaD
Budesonide—NR3C1—Adipogenesis—SOCS3—obesity	0.000135	0.00215	CbGpPWpGaD
Budesonide—Visual impairment—Topiramate—obesity	0.000135	0.000624	CcSEcCtD
Budesonide—Fluorometholone—NR3C1—obesity	0.000135	0.021	CrCbGaD
Budesonide—Gastrointestinal disorder—Bupropion—obesity	0.000135	0.000624	CcSEcCtD
Budesonide—Fatigue—Bupropion—obesity	0.000135	0.000623	CcSEcCtD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—obesity	0.000135	0.00214	CbGpPWpGaD
Budesonide—Pain—Bupropion—obesity	0.000134	0.000618	CcSEcCtD
Budesonide—Constipation—Bupropion—obesity	0.000134	0.000618	CcSEcCtD
Budesonide—Asthenia—Orlistat—obesity	0.000133	0.000614	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—PPARGC1A—obesity	0.000132	0.0021	CbGpPWpGaD
Budesonide—Hypersensitivity—Sibutramine—obesity	0.000132	0.00061	CcSEcCtD
Budesonide—Pruritus—Orlistat—obesity	0.000131	0.000606	CcSEcCtD
Budesonide—Eye disorder—Topiramate—obesity	0.000131	0.000605	CcSEcCtD
Budesonide—Methylprednisolone—NR3C1—obesity	0.00013	0.0203	CrCbGaD
Budesonide—Flushing—Topiramate—obesity	0.00013	0.000601	CcSEcCtD
Budesonide—Cardiac disorder—Topiramate—obesity	0.00013	0.000601	CcSEcCtD
Budesonide—Feeling abnormal—Bupropion—obesity	0.000129	0.000595	CcSEcCtD
Budesonide—Asthenia—Sibutramine—obesity	0.000129	0.000594	CcSEcCtD
Budesonide—Gastrointestinal pain—Bupropion—obesity	0.000128	0.000591	CcSEcCtD
Budesonide—Angiopathy—Topiramate—obesity	0.000127	0.000588	CcSEcCtD
Budesonide—Pruritus—Sibutramine—obesity	0.000127	0.000586	CcSEcCtD
Budesonide—Diarrhoea—Orlistat—obesity	0.000127	0.000586	CcSEcCtD
Budesonide—Immune system disorder—Topiramate—obesity	0.000127	0.000585	CcSEcCtD
Budesonide—Mediastinal disorder—Topiramate—obesity	0.000126	0.000584	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—obesity	0.000126	0.00199	CbGpPWpGaD
Budesonide—Urticaria—Bupropion—obesity	0.000124	0.000574	CcSEcCtD
Budesonide—Alopecia—Topiramate—obesity	0.000124	0.000572	CcSEcCtD
Budesonide—Body temperature increased—Bupropion—obesity	0.000123	0.000571	CcSEcCtD
Budesonide—Abdominal pain—Bupropion—obesity	0.000123	0.000571	CcSEcCtD
Budesonide—CYP3A4—Tryptophan metabolism—CYP2E1—obesity	0.000123	0.00196	CbGpPWpGaD
Budesonide—Mental disorder—Topiramate—obesity	0.000123	0.000567	CcSEcCtD
Budesonide—Diarrhoea—Sibutramine—obesity	0.000123	0.000567	CcSEcCtD
Budesonide—Dizziness—Orlistat—obesity	0.000122	0.000566	CcSEcCtD
Budesonide—Malnutrition—Topiramate—obesity	0.000122	0.000564	CcSEcCtD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—obesity	0.000122	0.00193	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CDKN2A—obesity	0.000122	0.00193	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—AR—obesity	0.000122	0.00193	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—obesity	0.000121	0.00192	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—LPL—obesity	0.000121	0.00192	CbGpPWpGaD
Budesonide—Flatulence—Topiramate—obesity	0.00012	0.000556	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—FOXO1—obesity	0.00012	0.0019	CbGpPWpGaD
Budesonide—Tension—Topiramate—obesity	0.00012	0.000553	CcSEcCtD
Budesonide—Dysgeusia—Topiramate—obesity	0.000119	0.000552	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—IFNG—obesity	0.000119	0.00188	CbGpPWpGaD
Budesonide—Dizziness—Sibutramine—obesity	0.000118	0.000548	CcSEcCtD
Budesonide—Nervousness—Topiramate—obesity	0.000118	0.000548	CcSEcCtD
Budesonide—Hydrocortisone—SHBG—obesity	0.000118	0.0184	CrCbGaD
Budesonide—NR3C1—Gene Expression—APOBEC1—obesity	0.000118	0.00188	CbGpPWpGaD
Budesonide—Back pain—Topiramate—obesity	0.000118	0.000545	CcSEcCtD
Budesonide—Vomiting—Orlistat—obesity	0.000118	0.000544	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—PPARD—obesity	0.000117	0.00186	CbGpPWpGaD
Budesonide—Muscle spasms—Topiramate—obesity	0.000117	0.000542	CcSEcCtD
Budesonide—Rash—Orlistat—obesity	0.000117	0.00054	CcSEcCtD
Budesonide—Dermatitis—Orlistat—obesity	0.000117	0.000539	CcSEcCtD
Budesonide—Headache—Orlistat—obesity	0.000116	0.000536	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—obesity	0.000116	0.00184	CbGpPWpGaD
Budesonide—Hypersensitivity—Bupropion—obesity	0.000115	0.000532	CcSEcCtD
Budesonide—Vision blurred—Topiramate—obesity	0.000115	0.000531	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—obesity	0.000114	0.00182	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—GNB3—obesity	0.000114	0.00182	CbGpPWpGaD
Budesonide—Tremor—Topiramate—obesity	0.000114	0.000528	CcSEcCtD
Budesonide—Vomiting—Sibutramine—obesity	0.000114	0.000527	CcSEcCtD
Budesonide—Ill-defined disorder—Topiramate—obesity	0.000113	0.000523	CcSEcCtD
Budesonide—Rash—Sibutramine—obesity	0.000113	0.000522	CcSEcCtD
Budesonide—Dermatitis—Sibutramine—obesity	0.000113	0.000522	CcSEcCtD
Budesonide—Anaemia—Topiramate—obesity	0.000113	0.000521	CcSEcCtD
Budesonide—Headache—Sibutramine—obesity	0.000112	0.000519	CcSEcCtD
Budesonide—Asthenia—Bupropion—obesity	0.000112	0.000518	CcSEcCtD
Budesonide—Agitation—Topiramate—obesity	0.000112	0.000518	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—BDNF—obesity	0.000111	0.00177	CbGpPWpGaD
Budesonide—Betamethasone—CYP19A1—obesity	0.000111	0.0173	CrCbGaD
Budesonide—Pruritus—Bupropion—obesity	0.000111	0.000511	CcSEcCtD
Budesonide—Triamcinolone—NR3C1—obesity	0.00011	0.0171	CrCbGaD
Budesonide—Nausea—Orlistat—obesity	0.00011	0.000509	CcSEcCtD
Budesonide—Malaise—Topiramate—obesity	0.00011	0.000508	CcSEcCtD
Budesonide—CYP3A4—Tryptophan metabolism—CYP19A1—obesity	0.00011	0.00174	CbGpPWpGaD
Budesonide—Vertigo—Topiramate—obesity	0.00011	0.000507	CcSEcCtD
Budesonide—Syncope—Topiramate—obesity	0.000109	0.000506	CcSEcCtD
Budesonide—Palpitations—Topiramate—obesity	0.000108	0.000498	CcSEcCtD
Budesonide—Loss of consciousness—Topiramate—obesity	0.000107	0.000496	CcSEcCtD
Budesonide—Diarrhoea—Bupropion—obesity	0.000107	0.000494	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—NR0B2—obesity	0.000107	0.0017	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NR1I3—obesity	0.000107	0.0017	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—PPARA—obesity	0.000107	0.00169	CbGpPWpGaD
Budesonide—Nausea—Sibutramine—obesity	0.000106	0.000492	CcSEcCtD
Budesonide—Cough—Topiramate—obesity	0.000106	0.000492	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL10—obesity	0.000106	0.00169	CbGpPWpGaD
Budesonide—Hypertension—Topiramate—obesity	0.000105	0.000487	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—obesity	0.000104	0.00166	CbGpPWpGaD
Budesonide—Myalgia—Topiramate—obesity	0.000104	0.00048	CcSEcCtD
Budesonide—Arthralgia—Topiramate—obesity	0.000104	0.00048	CcSEcCtD
Budesonide—Chest pain—Topiramate—obesity	0.000104	0.00048	CcSEcCtD
Budesonide—Anxiety—Topiramate—obesity	0.000103	0.000478	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—IRS2—obesity	0.000103	0.00164	CbGpPWpGaD
Budesonide—Dizziness—Bupropion—obesity	0.000103	0.000478	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—AGT—obesity	0.000103	0.00164	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—obesity	0.000103	0.00164	CbGpPWpGaD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000103	0.000477	CcSEcCtD
Budesonide—Discomfort—Topiramate—obesity	0.000103	0.000474	CcSEcCtD
Budesonide—Dry mouth—Topiramate—obesity	0.000102	0.000469	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—LEP—obesity	0.000101	0.00161	CbGpPWpGaD
Budesonide—Confusional state—Topiramate—obesity	0.0001	0.000464	CcSEcCtD
Budesonide—Prednisone—NR3C1—obesity	9.98e-05	0.0155	CrCbGaD
Budesonide—NR3C1—AP-1 transcription factor network—MMP9—obesity	9.97e-05	0.00158	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—obesity	9.96e-05	0.00158	CbGpPWpGaD
Budesonide—Vomiting—Bupropion—obesity	9.93e-05	0.000459	CcSEcCtD
Budesonide—Infection—Topiramate—obesity	9.89e-05	0.000457	CcSEcCtD
Budesonide—Rash—Bupropion—obesity	9.85e-05	0.000455	CcSEcCtD
Budesonide—Dermatitis—Bupropion—obesity	9.84e-05	0.000455	CcSEcCtD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—obesity	9.83e-05	0.00156	CbGpPWpGaD
Budesonide—Shock—Topiramate—obesity	9.79e-05	0.000453	CcSEcCtD
Budesonide—Headache—Bupropion—obesity	9.79e-05	0.000453	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—NR1I2—obesity	9.77e-05	0.00155	CbGpPWpGaD
Budesonide—Nervous system disorder—Topiramate—obesity	9.76e-05	0.000451	CcSEcCtD
Budesonide—Tachycardia—Topiramate—obesity	9.71e-05	0.000449	CcSEcCtD
Budesonide—Skin disorder—Topiramate—obesity	9.67e-05	0.000447	CcSEcCtD
Budesonide—Hyperhidrosis—Topiramate—obesity	9.62e-05	0.000445	CcSEcCtD
Budesonide—Anorexia—Topiramate—obesity	9.49e-05	0.000439	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—obesity	9.4e-05	0.00149	CbGpPWpGaD
Budesonide—Nausea—Bupropion—obesity	9.28e-05	0.000429	CcSEcCtD
Budesonide—Prednisolone—NR3C1—obesity	9.2e-05	0.0143	CrCbGaD
Budesonide—Musculoskeletal discomfort—Topiramate—obesity	9.07e-05	0.000419	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—IRS1—obesity	9.02e-05	0.00143	CbGpPWpGaD
Budesonide—Betamethasone—NR3C1—obesity	9.01e-05	0.014	CrCbGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—obesity	9.01e-05	0.00143	CbGpPWpGaD
Budesonide—Insomnia—Topiramate—obesity	9e-05	0.000416	CcSEcCtD
Budesonide—NR3C1—Gene Expression—CTNNBL1—obesity	8.96e-05	0.00142	CbGpPWpGaD
Budesonide—Paraesthesia—Topiramate—obesity	8.94e-05	0.000413	CcSEcCtD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—obesity	8.88e-05	0.00141	CbGpPWpGaD
Budesonide—Dyspnoea—Topiramate—obesity	8.87e-05	0.00041	CcSEcCtD
Budesonide—Somnolence—Topiramate—obesity	8.85e-05	0.000409	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—PPARG—obesity	8.81e-05	0.0014	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—obesity	8.76e-05	0.00139	CbGpPWpGaD
Budesonide—Dyspepsia—Topiramate—obesity	8.76e-05	0.000405	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—CYP26B1—obesity	8.69e-05	0.00138	CbGpPWpGaD
Budesonide—Decreased appetite—Topiramate—obesity	8.65e-05	0.0004	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—INS—obesity	8.64e-05	0.00137	CbGpPWpGaD
Budesonide—Gastrointestinal disorder—Topiramate—obesity	8.59e-05	0.000397	CcSEcCtD
Budesonide—Fatigue—Topiramate—obesity	8.58e-05	0.000397	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—CYP26B1—obesity	8.57e-05	0.00136	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—obesity	8.54e-05	0.00136	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	8.52e-05	0.00135	CbGpPWpGaD
Budesonide—Constipation—Topiramate—obesity	8.51e-05	0.000394	CcSEcCtD
Budesonide—Pain—Topiramate—obesity	8.51e-05	0.000394	CcSEcCtD
Budesonide—NR3C1—Endoderm Differentiation—TGFB1—obesity	8.41e-05	0.00134	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IGF1—obesity	8.35e-05	0.00133	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—obesity	8.28e-05	0.00132	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MYC—obesity	8.24e-05	0.00131	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—TGFB1—obesity	8.22e-05	0.00131	CbGpPWpGaD
Budesonide—Feeling abnormal—Topiramate—obesity	8.2e-05	0.000379	CcSEcCtD
Budesonide—Gastrointestinal pain—Topiramate—obesity	8.14e-05	0.000376	CcSEcCtD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—obesity	8.08e-05	0.00128	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—SERPINE1—obesity	7.93e-05	0.00126	CbGpPWpGaD
Budesonide—Urticaria—Topiramate—obesity	7.91e-05	0.000366	CcSEcCtD
Budesonide—Abdominal pain—Topiramate—obesity	7.87e-05	0.000364	CcSEcCtD
Budesonide—Body temperature increased—Topiramate—obesity	7.87e-05	0.000364	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—ADH1B—obesity	7.62e-05	0.00121	CbGpPWpGaD
Budesonide—Hypersensitivity—Topiramate—obesity	7.33e-05	0.000339	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—obesity	7.33e-05	0.00116	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—obesity	7.3e-05	0.00116	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—obesity	7.2e-05	0.00114	CbGpPWpGaD
Budesonide—Asthenia—Topiramate—obesity	7.14e-05	0.00033	CcSEcCtD
Budesonide—Pruritus—Topiramate—obesity	7.04e-05	0.000326	CcSEcCtD
Budesonide—Hydrocortisone—NR3C1—obesity	7.04e-05	0.011	CrCbGaD
Budesonide—Diarrhoea—Topiramate—obesity	6.81e-05	0.000315	CcSEcCtD
Budesonide—Dizziness—Topiramate—obesity	6.58e-05	0.000304	CcSEcCtD
Budesonide—Dexamethasone—CYP19A1—obesity	6.47e-05	0.0101	CrCbGaD
Budesonide—Vomiting—Topiramate—obesity	6.33e-05	0.000293	CcSEcCtD
Budesonide—Rash—Topiramate—obesity	6.28e-05	0.00029	CcSEcCtD
Budesonide—Dermatitis—Topiramate—obesity	6.27e-05	0.00029	CcSEcCtD
Budesonide—Triamcinolone—PTGS2—obesity	6.24e-05	0.00972	CrCbGaD
Budesonide—Headache—Topiramate—obesity	6.23e-05	0.000288	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—IL6—obesity	6.19e-05	0.000984	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PARP1—obesity	6.14e-05	0.000975	CbGpPWpGaD
Budesonide—Nausea—Topiramate—obesity	5.91e-05	0.000273	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—SULT2A1—obesity	5.87e-05	0.000932	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—ESR2—obesity	5.81e-05	0.000923	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—SULT2A1—obesity	5.79e-05	0.000919	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PPARD—obesity	5.65e-05	0.000897	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—obesity	5.57e-05	0.000885	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GPX3—obesity	5.52e-05	0.000877	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—obesity	5.46e-05	0.000867	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—STAT3—obesity	5.4e-05	0.000858	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—NCOA1—obesity	5.35e-05	0.000851	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—obesity	5.34e-05	0.000848	CbGpPWpGaD
Budesonide—Dexamethasone—NR3C1—obesity	5.24e-05	0.00816	CrCbGaD
Budesonide—NR3C1—Gene Expression—NR0B2—obesity	5.14e-05	0.000817	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NR1I3—obesity	5.14e-05	0.000817	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—AR—obesity	5.13e-05	0.000816	CbGpPWpGaD
Budesonide—Betamethasone—PTGS2—obesity	5.11e-05	0.00796	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—obesity	5.08e-05	0.000808	CbGpPWpGaD
Budesonide—Prednisone—ALB—obesity	5.05e-05	0.00785	CrCbGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—obesity	5.03e-05	0.0008	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TGFB1—obesity	5.01e-05	0.000796	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—AKR1C3—obesity	4.84e-05	0.000769	CbGpPWpGaD
Budesonide—Dexamethasone—CYP2E1—obesity	4.83e-05	0.00751	CrCbGaD
Budesonide—NR3C1—Gene Expression—NR1I2—obesity	4.7e-05	0.000747	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—TNF—obesity	4.68e-05	0.000743	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—obesity	4.33e-05	0.000687	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP2E1—obesity	4.29e-05	0.000682	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP2E1—obesity	4.23e-05	0.000672	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TNF—obesity	4.04e-05	0.000642	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GGT1—obesity	3.94e-05	0.000626	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PPARA—obesity	3.89e-05	0.000618	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—NCOA1—obesity	3.88e-05	0.000616	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP19A1—obesity	3.82e-05	0.000607	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—IL6—obesity	3.77e-05	0.0006	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP19A1—obesity	3.77e-05	0.000599	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CA3—obesity	3.58e-05	0.000568	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—COMT—obesity	3.55e-05	0.000565	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—ESR1—obesity	3.52e-05	0.00056	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—COMT—obesity	3.51e-05	0.000557	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6—obesity	3.26e-05	0.000518	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—PPARG—obesity	3.22e-05	0.000511	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GLRX—obesity	3.04e-05	0.000483	CbGpPWpGaD
Budesonide—Dexamethasone—PTGS2—obesity	2.98e-05	0.00463	CrCbGaD
Budesonide—NR3C1—Gene Expression—PARP1—obesity	2.95e-05	0.000469	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—SERPINE1—obesity	2.9e-05	0.00046	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ESR2—obesity	2.8e-05	0.000445	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ETFDH—obesity	2.71e-05	0.000431	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPM1L—obesity	2.71e-05	0.000431	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—INSIG2—obesity	2.71e-05	0.000431	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—OTC—obesity	2.71e-05	0.000431	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NCOA1—obesity	2.58e-05	0.00041	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—INPP5E—obesity	2.48e-05	0.000394	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPT—obesity	2.48e-05	0.000394	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UQCRC2—obesity	2.48e-05	0.000394	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AR—obesity	2.47e-05	0.000393	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ME1—obesity	2.31e-05	0.000366	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALDH6A1—obesity	2.31e-05	0.000366	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SUCLG2—obesity	2.31e-05	0.000366	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—POMC—obesity	2.3e-05	0.000365	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SIRT1—obesity	2.25e-05	0.000358	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UCP1—obesity	2.17e-05	0.000344	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PNPLA3—obesity	2.17e-05	0.000344	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—COX7C—obesity	2.17e-05	0.000344	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CS—obesity	2.05e-05	0.000326	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—DGAT2—obesity	2.05e-05	0.000326	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SUCLA2—obesity	2.05e-05	0.000326	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CPS1—obesity	2.05e-05	0.000326	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MUT—obesity	1.96e-05	0.000311	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LIPE—obesity	1.96e-05	0.000311	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PRKCD—obesity	1.95e-05	0.00031	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—DGAT1—obesity	1.88e-05	0.000299	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYB5A—obesity	1.88e-05	0.000299	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PPARA—obesity	1.87e-05	0.000298	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—MYC—obesity	1.83e-05	0.000291	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACLY—obesity	1.81e-05	0.000287	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALOX12—obesity	1.75e-05	0.000278	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ENPP1—obesity	1.75e-05	0.000278	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ESR1—obesity	1.7e-05	0.00027	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HMGCS1—obesity	1.69e-05	0.000269	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SAT1—obesity	1.64e-05	0.000261	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PLIN1—obesity	1.64e-05	0.000261	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PNPLA2—obesity	1.64e-05	0.000261	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACADM—obesity	1.64e-05	0.000261	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PFKFB3—obesity	1.64e-05	0.000261	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ANGPTL4—obesity	1.64e-05	0.000261	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACACB—obesity	1.6e-05	0.000254	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYTB—obesity	1.6e-05	0.000254	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—OXCT1—obesity	1.6e-05	0.000254	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PNLIP—obesity	1.56e-05	0.000247	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SRD5A1—obesity	1.56e-05	0.000247	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—PPARG—obesity	1.55e-05	0.000246	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SDC3—obesity	1.52e-05	0.000241	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP26B1—obesity	1.49e-05	0.000236	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—STS—obesity	1.49e-05	0.000236	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HK2—obesity	1.49e-05	0.000236	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARD—obesity	1.45e-05	0.000231	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC27A1—obesity	1.42e-05	0.000226	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GLUL—obesity	1.4e-05	0.000222	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—FABP4—obesity	1.4e-05	0.000222	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SERPINE1—obesity	1.39e-05	0.000222	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UCP3—obesity	1.32e-05	0.00021	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSD11B1—obesity	1.32e-05	0.00021	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UCP2—obesity	1.32e-05	0.00021	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ECHS1—obesity	1.32e-05	0.00021	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ADH1B—obesity	1.3e-05	0.000207	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACSL1—obesity	1.28e-05	0.000204	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPAM—obesity	1.28e-05	0.000204	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARGC1B—obesity	1.28e-05	0.000204	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PCK1—obesity	1.24e-05	0.000198	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HADH—obesity	1.24e-05	0.000198	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—FADS1—obesity	1.24e-05	0.000198	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ACP5—obesity	1.21e-05	0.000192	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—G6PD—obesity	1.18e-05	0.000187	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SREBF2—obesity	1.17e-05	0.000185	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HK1—obesity	1.17e-05	0.000185	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LPA—obesity	1.13e-05	0.000179	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LPIN1—obesity	1.1e-05	0.000175	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOA5—obesity	1.08e-05	0.000171	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC22A1—obesity	1.03e-05	0.000164	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CLOCK—obesity	1.03e-05	0.000164	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SULT2A1—obesity	1e-05	0.000159	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GLP1R—obesity	1e-05	0.000159	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—DPYD—obesity	9.87e-06	0.000157	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PRKAR2B—obesity	9.5e-06	0.000151	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—DCN—obesity	9.43e-06	0.00015	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CPT1A—obesity	9.18e-06	0.000146	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NAMPT—obesity	9e-06	0.000143	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LIPC—obesity	8.94e-06	0.000142	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GCK—obesity	8.94e-06	0.000142	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOC3—obesity	8.89e-06	0.000141	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MYC—obesity	8.83e-06	0.00014	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CETP—obesity	8.63e-06	0.000137	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SDC1—obesity	8.53e-06	0.000136	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKR1C3—obesity	8.39e-06	0.000133	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SCARB1—obesity	8.26e-06	0.000131	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SREBF1—obesity	8.02e-06	0.000127	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GOT2—obesity	7.8e-06	0.000124	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—FASN—obesity	7.64e-06	0.000121	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—BCHE—obesity	7.6e-06	0.000121	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP2E1—obesity	7.34e-06	0.000117	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NQO1—obesity	7.25e-06	0.000115	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SLC2A4—obesity	6.95e-06	0.00011	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GCG—obesity	6.95e-06	0.00011	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYCS—obesity	6.86e-06	0.000109	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GGT1—obesity	6.74e-06	0.000107	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GOT1—obesity	6.74e-06	0.000107	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOA1—obesity	6.63e-06	0.000105	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—STK11—obesity	6.54e-06	0.000104	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP19A1—obesity	6.54e-06	0.000104	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AKT1—obesity	6.12e-06	9.72e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—COMT—obesity	6.08e-06	9.66e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARGC1A—obesity	5.99e-06	9.52e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GNB3—obesity	5.99e-06	9.52e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HMOX1—obesity	5.97e-06	9.48e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GNAS—obesity	5.84e-06	9.27e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOB—obesity	5.72e-06	9.08e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—LPL—obesity	5.46e-06	8.67e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GPX1—obesity	5.32e-06	8.46e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CD36—obesity	5.19e-06	8.24e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTHFR—obesity	4.91e-06	7.81e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARA—obesity	4.82e-06	7.66e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AGT—obesity	4.67e-06	7.42e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOE—obesity	4.57e-06	7.27e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CAV1—obesity	4.53e-06	7.2e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOA1—obesity	4.52e-06	7.18e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CG—obesity	4.13e-06	6.56e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPARG—obesity	3.98e-06	6.33e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—POMC—obesity	3.93e-06	6.24e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—INS—obesity	3.91e-06	6.21e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CD—obesity	3.63e-06	5.77e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALB—obesity	3.58e-06	5.69e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NOS3—obesity	3.43e-06	5.44e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3R1—obesity	3.43e-06	5.44e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CB—obesity	3.16e-06	5.03e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTGS2—obesity	3.13e-06	4.98e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CA—obesity	1.93e-06	3.06e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKT1—obesity	1.58e-06	2.5e-05	CbGpPWpGaD
